Scholar Rock Holding Corp financial data

Symbol
SRRK on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
301 Binney Street, 3 Rd Floor, Cambridge, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 670 % -30.8%
Debt-to-equity 50.2 % +22.7%
Return On Equity -129 % -60.2%
Return On Assets -85.8 % -50.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 94.7M shares +21.6%
Common Stock, Shares, Outstanding 93.8M shares +23.5%
Entity Public Float 395M USD +149%
Common Stock, Value, Issued 94K USD +23.7%
Weighted Average Number of Shares Outstanding, Basic 99.8M shares +19.8%
Weighted Average Number of Shares Outstanding, Diluted 99.8M shares +19.8%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 185M USD +51.4%
General and Administrative Expense 67.5M USD +36.7%
Operating Income (Loss) -252M USD -47.1%
Nonoperating Income (Expense) 5.76M USD +4.61%
Net Income (Loss) Attributable to Parent -246M USD -48.6%
Earnings Per Share, Basic -2.47 USD/shares -24.1%
Earnings Per Share, Diluted -2.47 USD/shares -24.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 178M USD +74.6%
Marketable Securities, Current 259M USD +45.7%
Assets, Current 451M USD +56.5%
Property, Plant and Equipment, Net 2.76M USD -40%
Operating Lease, Right-of-Use Asset 15.6M USD +37%
Other Assets, Noncurrent 2.95M USD -33.3%
Assets 475M USD +52.7%
Accounts Payable, Current 10.1M USD +191%
Employee-related Liabilities, Current 14.8M USD +39.5%
Accrued Liabilities, Current 31.1M USD +51.9%
Liabilities, Current 46.9M USD +43.4%
Operating Lease, Liability, Noncurrent 9.21M USD +110%
Liabilities 106M USD +23.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 160K USD +73.9%
Retained Earnings (Accumulated Deficit) -923M USD -36.4%
Stockholders' Equity Attributable to Parent 369M USD +63.7%
Liabilities and Equity 475M USD +52.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -49.8M USD -15.6%
Net Cash Provided by (Used in) Financing Activities 6.53M USD +506%
Net Cash Provided by (Used in) Investing Activities 33.4M USD -62.9%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 93.8M shares +23.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.88M USD -121%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 180M USD +72.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.66M USD +11.1%
Deferred Tax Assets, Valuation Allowance 293M USD +35.3%
Deferred Tax Assets, Gross 298M USD +35.1%
Operating Lease, Liability 15M USD +26.9%
Payments to Acquire Property, Plant, and Equipment 23K USD -23.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -246M USD -49.4%
Lessee, Operating Lease, Liability, to be Paid 17.6M USD +40.4%
Property, Plant and Equipment, Gross 16M USD +0.33%
Operating Lease, Liability, Current 5.77M USD -22.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 6.43M USD +43%
Lessee, Operating Lease, Liability, to be Paid, Year One 7.37M USD -8.48%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure +78.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.64M USD +252%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.82M USD
Deferred Tax Assets, Operating Loss Carryforwards 139M USD +26.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 1.98M USD -15.4%
Additional Paid in Capital 1.29B USD +43.2%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 4.51M USD +20.1%
Share-based Payment Arrangement, Expense 36.6M USD +35%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%